Evolus, Inc. (EOLS) 是一家上市公司 属于 医疗保健 板块，经营于 制药 - 专科与仿制药 行业. 公司总部位于 Newport Beach, CA, 美国. 现任CEO为 David Moatazedi.
EOLS 拥有 IPO日期为 2018-02-08, 372 名全职员工, 在 NASDAQ Global Market, 市值为 $288.87M.
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
